How a $7.4 billion settlement with Purdue Pharma, Sackler family could help Colorado communities tackle the opioid crisis
- Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma and the Sackler family for their role in the opioid crisis.
- The funds will be distributed over the next 15 years to support opioid addiction treatment, prevention, and recovery programs in 19 Colorado regions and 78 local governments.
- The settlement follows a prior agreement rejected by the Supreme Court, which ruled the Sackler family was not entitled to immunity from future opioid lawsuits.
- If approved, over 30 million documents related to Purdue Pharma's opioid business would be made public, and the company will be monitored to prevent lobbying or marketing of opioids.
14 Articles
14 Articles
Attorney General Jennings helps secure $7.4 billion from Purdue Pharma and the Sackler family
Delaware Attorney General Kathy Jennings announced that she, along with a bipartisan coalition of negotiating attorneys general, has reached a $7.4 billion settlement in principle with members of the Sackler family and their company Purdue Pharma, Inc. (Purdue) for their instrumental role in creating the opioid crisis.“This is a bittersweet moment for everyone who has continued to fight to hold the Sacklers and Purdue accountable,” said AG Jenni…
Readers Offer Their Takes on the Opioid Crisis, Family Doctor Shortage, and Vaccine Policies
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. A chronic-pain patient advocate, who has been featured previously in KFF Health News coverage, spoke out on the social platform X about our “Payback: Tracking the Opioid Settlement Cash” project: Oh, look an entire investigation, of course partly by shatterproof, looking at where the settlement…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium







